Skip to search formSkip to main contentSkip to account menu

Leishmaniasis, Visceral

Known as: azar kala, Leishmaniasis, Visceral [Disease/Finding], Black Fever 
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is… 
National Institutes of Health

Related topics

Related topics

17 relations
Amphotericin 100mg powder for infusion solution vialAmphotericin BAmphotericin B Colloidal DispersionIn Blood

Broader (1)

Leishmaniasis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment… 
Review
2014
Review
2014
Epidemiology of visceral leishmaniasis
Leishmania species are the causative agents of leishmaniasis, a neglected tropical disease. These parasitic protozoans are… 
Highly Cited
2010
Highly Cited
2010
Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
BACKGROUND Some 50% of patients with visceral leishmaniasis (kala-azar) worldwide live in the Indian state of Bihar. Liposomal… 
Review
2008
Review
2008
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
SUMMARY To date, most Leishmania and human immunodeficiency virus (HIV) coinfection cases reported to WHO come from Southern… 
Review
2006
Review
2006
Drug Resistance in Leishmaniasis
SUMMARY Leishmaniasis is a complex disease, with visceral and cutaneous manifestations, and is caused by over 15 different… 
Highly Cited
2002
Highly Cited
2002
Oral miltefosine for Indian visceral leishmaniasis.
BACKGROUND There are 500,000 cases per year of visceral leishmaniasis, which occurs primarily in the Indian subcontinent. Almost… 
Highly Cited
2002
Highly Cited
2002
Comparison of Six PCR Methods Using Peripheral Blood for Detection of Canine Visceral Leishmaniasis
ABSTRACT The objectives of this study were to compare the sensitivities and reliabilities of different PCR methods for the… 
Highly Cited
2001
Highly Cited
2001
Drug resistance in Indian visceral leishmaniasis
Throughout the world, pentavalent antimonial compounds (Sbv) have been the mainstay of antileishmanial therapy for more than 50… 
Highly Cited
1999
Highly Cited
1999
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.
BACKGROUND There is no effective orally administered medication for any leishmania infection. We investigated miltefosine, which… 
Highly Cited
1993
Highly Cited
1993
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.
We report the cloning of a Leishmania chagasi antigen gene and an evaluation of leishmaniasis patient antibody responses to the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)